Drug Detail

Information about Imatinib + Atezolizumab

Generic Name	Imatinib + Atezolizumab
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery	Oral and intravenous
Approval Status
Indications
Overall Strategy	KIT Protein and immune system
Strategy	Block KIT + Unblock cell death genes
Drug Category	KIT/PDGFRA inhibitor + PD-L1 inhibitor

Links
Trials of this drug
	A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)

Trial results